ESC 365 - CRISPR/Cas9-mediated Disruption of the Human R14del Mutation Suppresses Arrhythmias in a Novel Humanized Mouse Model of Arrhythmogenic Cardiomyopathy

ESC Premium Access

CRISPR/Cas9-mediated Disruption of the Human R14del Mutation Suppresses Arrhythmias in a Novel Humanized Mouse Model of Arrhythmogenic Cardiomyopathy

Session: Late Breaking Basic and Translational Science - Cardiac Biology

Topic: Arrhythmias

Speaker: Doctor N. Raad (New York, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Nour Raad

Mount Sinai School of Medicine, New York (United States of America)

1 presentation

0 follower

5 more presentations in this session

Impaired Excitation Contraction Coupling in Human Induced Pluripotent Stem Cell Derived Cardiac Myocytes from Arrhythmogenic Right Ventricular Cardiomyopathy Patients with a Plakophilin2 Mutation

Speaker: Doctor K. Hammer (Regensburg, DE)

Arrhythmogenic Cardiomyopathy type 8 zebrafish models: opportunities for the identification of early pathogenetic events and new therapeutic targets

Speaker: Associate Professor N. Tiso (Padova, IT)

BNP signal peptide protects the heart from ischemia-reperfusion injury

Speaker: Professor C. Pemberton (Christchurch, NZ)

Mutations contributing to clonal hematopoiesis are associated with poor prognosis in chronic ischemic heart failure

Speaker: Professor B. Assmus (Giessen, DE)

The SIRT1 activator resveratrol ameliorates dystrophic cardiomyopathy by promoting mitophagy.

Speaker: Professor A. Kuno (Sapporo, JP)

Access the full session

Late Breaking Basic and Translational Science - Cardiac Biology

Speakers: Doctor N. Raad, Doctor K. Hammer, Associate Professor N. Tiso, Professor C. Pemberton, Professor B. Assmus...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources